Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma

Running, not enrolling · Not applicable

Conditions studied: Lymphoma

In brief

To learn more about the usefulness of molecular testing with the Molecular Functional (MF) Portrait (a commercial test conducted by the sponsor of this study, BostonGene) in guiding lymphoma care.

Key facts

Study ID

NCT05464823

Run by

M.D. Anderson Cancer Center

People needed

111

Starts

2022-07-07

Expected to finish

2027-05-12

Last updated by the study team

2026-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male/female patients who are at least 18 years of age on the day of informed consent signing.
• Patients must have a histologically documented diffuse large B-cell lymphoma requiring therapy.
• Provision of written informed consent for the study.

You may not qualify if…

• None

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.